{"title":"J&J vaccine supply has run out; Emergent says it’s working on improvements","link":"https://arstechnica.com/?p=1764475","date":1620831432000,"content":"<div>\n<figure><img src=\"https://cdn.arstechnica.net/wp-content/uploads/2021/04/GettyImages-1232202977-800x533.jpeg\" /><p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2021/04/GettyImages-1232202977.jpeg\">Enlarge</a> <span>/</span> The Emergent BioSolutions plant, a manufacturing partner for Johnson &amp; Johnson's COVID-19 vaccine, in Baltimore, Maryland, on April 9, 2021.  (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/the-emergent-biosolutions-plant-a-manufacturing-partner-for-news-photo/1232202977?adppopup=true\">Getty | Saul Loeb</a>)</p>  </figure><div><a name=\"page-1\"></a></div>\n<p>States will not receive shipments of Johnson &amp; Johnson’s one-shot COVID-19 vaccine next week, <a href=\"https://www.politico.com/news/2021/05/11/states-johnson-johnson-vaccine-487070\">according to a report by Politico</a>.</p>\n<p>White House officials told governors in a call Tuesday that there are no new doses available for order. It’s unclear if the federal government will be able to distribute doses through other channels, such as those that provide vaccines directly to pharmacies and community health centers.</p>\n<p>The dried-up supply is just the latest trouble for Johnson &amp; Johnson, which has consistently struggled to produce its vaccine in the US.</p></div><p><a href=\"https://arstechnica.com/?p=1764475#p3\">Read 6 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=1764475&amp;comments=1\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"b4f2152c167f80b9de83defc3270f60c0a7946db56087dfaf2ed23838b9651b0","category":"Tech"}